RecruitMe Clinical Trial

A Multicenter, Randomized, Parallel Group, Double-Blind, Multiple Dose, Placebo-Controlled Study to Assess the Efficacy and Safety of MNK-1411 in Male Subjects 4 to 8 Years of Age With Duchenne Muscular Dystrophy
Brave Trial, A Clinical Research Study for Duchenne Muscular Dystrophy (DMD)
Sponsor:Mallinckrodt
Enrolling:Male Patients Only
Study Length:14 Months
Age Range:Between 4 and 8 years old
IRB Number:AAAR7151
U.S. Government ID:NCT03400852
Contact: Ameneh Onativia: 212-342-3679 / am2959@cumc.columbia.edu
Additional Study Information:

Our clinic is currently participating in the Brave Trial, a clinical research study for Duchenne muscular dystrophy (DMD). This study is being conducted to learn whether a study drug can improve motor functions in boys with DMD. If your child takes part, he'll receive at no cost: study drug or placebo, study-related procedures, reimbursement for reasonable expenses.

Do You Qualify?
Has the patient been diagnosed with Duchenne muscular dystrophy?YesNo
Is the patient a male?YesNo
Is he at least 4 years old?YesNo
Is he younger than 9 years old?YesNo
Submit
Cancel
Investigator
Darryl De Vivo, MD
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Ameneh Onativia
Email: am2959@cumc.columbia.edu
Phone: 212-342-3679